Stonehearth Capital Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$224K Buy
+1,775
New +$234K 0.08% 83
2024
Q1
Sell
-3,221
Closed -$261K 80
2023
Q4
$261K Buy
3,221
+359
+13% +$27.9K 0.13% 62
2023
Q3
$214K Buy
+2,862
New +$220K 0.12% 63

Other funds holding GILD

Stonehearth Capital Management's GILD Position: Q2 2026 in Review

Stonehearth Capital Management opened a new position in Gilead Sciences (GILD) in Q2 2026: 1,775 shares worth $224K. The stake represents 0.08% of the portfolio and ranks #83 among its holdings. This is a return to the name: Stonehearth Capital Management previously reported a position in GILD as recently as Q4 2023.

Stonehearth Capital Management first reported a position in GILD in Q3 2023 and has held it in 3 quarters since. The position peaked at $261K in Q4 2023. 361 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Stonehearth Capital Management held 1,775 shares of Gilead Sciences worth $224K as of Q2 2026.
  • Gilead Sciences was a new Stonehearth Capital Management position in Q2 2026.
  • Gilead Sciences made up 0.08% of Stonehearth Capital Management's portfolio in Q2 2026, its #83 holding.
  • Stonehearth Capital Management first reported a position in Gilead Sciences in Q3 2023 and has held it in 3 quarters since.
  • Stonehearth Capital Management's Gilead Sciences position peaked at $261K in Q4 2023.
  • 361 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Stonehearth Capital Management's 13F filing for Q2 2026, filed 7 Jul 2026.